| Medtronic plc | $111.0b | $85.80 | -0.6% | 532.5K | |
| Edwards Lifesciences Corp | $49.6b | $90.44 | +0.7% | 575.7K | |
| Alcon Inc. Ordinary Shares | $33.6b | $70.70 | -0.7% | 170.4K | |
| Biogen Inc. Common Stock | $30.0b | $211.39 | +1.0% | 70.3K | |
| Zimmer Biomet Holdings, Inc. | $18.8b | $99.39 | +2.9% | 927.3K | |
| Glaukos Corporation | $9.8b | $169.07 | -0.8% | 32.1K | |
| Bausch + Lomb Corporation | $6.0b | $16.68 | -0.1% | 16.7K | |
| Denali Therapeutics Inc. Common Stock | $3.7b | $24.38 | +0.7% | 146.6K | |
| Bioventus Inc. Class A Common Stock | $0.9b | $15.30 | +9.9% | 723.7K | |
| Anteris Technologies Global Corp. Common Stock | $0.8b | $8.23 | -0.2% | 50.7K | |
| BioAge Labs, Inc. Common Stock | $401.9m | $11.38 | +2.4% | 106.6K | |
| AC Immune SA | $222.9m | $2.35 | +1.3% | 48.3K | |
| Alpha Cognition Inc. Common Stock | $180.3m | $9.08 | +1.7% | 11.4K | |
| Outlook Therapeutics, Inc. Common Stock | $170.7m | $1.03 | +4.1% | 1.5M | |
| Alector, Inc. Common Stock | $167.6m | $1.55 | +1.6% | 17.2K | |
| LENZ Therapeutics, Inc. Common Stock | $166.2m | $5.36 | +2.4% | 177.7K | |
| Acumen Pharmaceuticals, Inc. Common Stock | $155.3m | $2.25 | +2.2% | 25.9K | |
| Telomir Pharmaceuticals, Inc. Common Stock | $85.3m | $1.19 | 0.0% | 9.0K | |
| Cognition Therapeutics, Inc. Common Stock | $79.6m | $1.03 | +6.0% | 309.9K | |
| Annovis Bio, Inc. | $74.4m | $1.94 | +5.1% | 205.7K | |
| Envoy Medical, Inc. Class A Common Stock | $51.7m | $0.71 | 0.0% | 2.8K | |
| Greenland Mines Ltd. Common Stock | $29.2m | $0.18 | -3.5% | 644.1K | |
| CervoMed Inc. Common Stock | $23.9m | $2.79 | -1.6% | 56.5K | |
| Longeveron Inc. Common Stock | $22.2m | $0.76 | +5.2% | 53.9K | |
| NeuroSense Therapeutics Ltd. Ordinary Shares | $16.9m | $0.57 | +3.9% | 74.0K | |
| OSR Health, Inc. Common Stock | $15.7m | $0.45 | 0.0% | 29.2K | |
| Alzamend Neuro, Inc. Common Stock | $6.3m | $1.41 | 0.0% | 15.1K | |
| 20/20 Biolabs, Inc. Common Stock | $5.2m | $0.45 | 0.0% | 33.0K | |
| HCW Biologics Inc. Common Stock | $5.1m | $3.60 | 0.0% | 9.3K | |
| FibroBiologics, Inc. Common Stock | $4.3m | $0.85 | 0.0% | 48.7K |